<DOC>
	<DOCNO>NCT00872300</DOCNO>
	<brief_summary>The purpose study determine antitumor activity PHA-739358 single agent IV infusion adult patient Multiple Myeloma history least 2 previous line treatment disease .</brief_summary>
	<brief_title>PHA-739358 Treatment Multiple Myeloma</brief_title>
	<detailed_description />
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<criteria>active multiple myeloma progress least 2 prior line treatment measurable disease ( 4 ; 14 ) translocation life expectancy least 3 month uncontrolled hypertension myocardial infarction , unstable angina , symptomatic congestive heart failure , cerebrovascular accident past 6 month . pregnancy breast feed active infection , include HIV</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>